Searched for
PHARMA INTERMEDIATES
Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...- Sensex down over 10K points from Dec peak. Should MF investors buy the dip, hold positions, or wait on sidelines?The BSE Sensex has fallen over 10,000 points from its peak. Market experts suggest this presents a buying opportunity for long-term investo...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- 20 months of bearish markets: One additional letter that tells you which 'cheap' stocks are actually cheapMost investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...
- Dalal Street Week Ahead: Nifty stuck in consolidation zone; 23,800 remains key breakout hurdleMarkets experienced volatility and ended the week with a modest loss, primarily due to MSCI rebalancing flows. Nifty consolidated within a ...
- Sensex slips 250 pts, Nifty at 24,000 as US strike on Iran dent sentiment; mid, smallcaps outperformBenchmark indices Nifty and Sensex traded marginally lower on Tuesday, impacted by US attacks in southern Iran, reigniting fears of a prolo...
- Nifty likely to trade in a range; 23,800 a key breakout hurdleNifty is expected to trade rangebound with a mild bullish undertone this week, consolidating amid mixed cues. Analysts see 23,800-24,000 as...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Rising input costs, export slump take a toll on drug companies' healthAccording to industry executives, the modest price hike of 0.6% that the government has allowed on essential medicines effective April 1 is...
- Specialty chemicals: Is China still the same threat, or is this a contrarian moment? 7 stocks to be brought back on the watchlistWhen it comes to the Indian speciality chemicals sector, China and its dumping matters. But there have been subtle but significant changes ...
- Secular, cyclical or war-dependent: A ratio to tell you what kind of growth you are buying. 6 stocks with upside potential of up to 29%Some valuation ratios are used because they are easy. The PE ratio is one of them. It is simple, familiar, and convenient. Not only for the...
- Markets likely near bottom range; stay invested: Devina MehraDevina Mehra of First Global believes Indian equity markets are in a bottoming zone, advising investors to stay invested. She anticipates 2...
- Nifty stays range bound as volatility rises; breakout awaitedNifty 50 traded within a narrow range, closing slightly higher amid rising volatility and weak momentum indicators. Markets remain in conso...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Ahead of Market: 10 things that will decide stock market action on WednesdayNifty 50 and BSE Sensex declined amid selling in banking, auto and IT stocks. Markets remain range-bound, awaiting triggers, with analysts ...
- Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang VohraShares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...
- Dalal Street Week Ahead: Nifty’s next big move hinges on support test; volatility set to stay highThe Nifty ended the week under pressure, slipping into a corrective phase as volatility surged. With the index hovering near crucial suppor...
- Why stock market fell today? Sensex plunges 850 pts, Nifty below 24,200. 6 reasons behind selloffIndian equity benchmarks declined for a second straight session, pressured by a spike in crude oil prices, a weakening rupee and rising geo...
- Bonus issue & stock split: Last day to buy shares of this smallcap company before record date. Do you own?Anlon Healthcare's shares will trade ex-record date tomorrow for its 1:1 bonus issue and 1:5 stock split, making today the last chance for ...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
Load More
